Search
ALX Oncology Holdings Inc
ALXOAdd to Watchlist
1.700USD
-0.040-2.30%
Close 09-18 16:00（ET）
233.59MMarket Cap
LossP/E TTM
ALXO Financials
See ALX Oncology Holdings Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
233.59M
Dividend TTM
0.00
P/E TTM
-1.13
EPS TTM
-1.49
Revenue
--
Net Profit
-134.85M
ROE
-74.17%
ROA
-59.40%
ALX Oncology Holdings Inc Earnings Date
Latest Release
Aug 6, 2026
EPS / Forecast
-0.13/-0.14
Revenue / Forecast
--/0.00
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of ALX Oncology Holdings Inc?
According to ALX Oncology Holdings Inc's FY2025 earnings report, its current assets were 50.73M, with a year-on-year change of -62.24.
What are the total assets of ALX Oncology Holdings Inc?
According to ALX Oncology Holdings Inc's FY2025 earnings report, its total assets of ALX Oncology Holdings Inc were 59.05M, with a year-on-year change of -60.04.
What are the total liabilities of ALX Oncology Holdings Inc?
According to ALX Oncology Holdings Inc's FY2025 earnings report, its total liabilities of ALX Oncology Holdings Inc were 33.06M, with a year-on-year change of -3.20.
What is the total equity of ALX Oncology Holdings Inc?
According to ALX Oncology Holdings Inc's FY2025 earnings report, its total equity of ALX Oncology Holdings Inc was 25.98M, with a year-on-year change of -77.13.
What is the net operating income of ALX Oncology Holdings Inc?
According to ALX Oncology Holdings Inc's FY2025 earnings report, its net operating income of ALX Oncology Holdings Inc was -100.85M, with a year-on-year change of 29.21.
What is the net investment of ALX Oncology Holdings Inc?
According to ALX Oncology Holdings Inc's FY2025 earnings report, its net investment of ALX Oncology Holdings Inc was 82.59M, with a year-on-year change of -4.25.
What is the net financing of ALX Oncology Holdings Inc?
According to ALX Oncology Holdings Inc's FY2025 earnings report, its net financing of ALX Oncology Holdings Inc was 362.00K, with a year-on-year change of -98.83.
What is the Earnings Per Share (EPS) of ALX Oncology Holdings Inc?
According to ALX Oncology Holdings Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.90, with a year-on-year change of 26.67.
What is the net income of ALX Oncology Holdings Inc?
According to ALX Oncology Holdings Inc's FY2025 earnings report, its net income was -101.69M, with a year-on-year change of 24.59.
What is the debt-to-asset ratio of ALX Oncology Holdings Inc?
According to ALX Oncology Holdings Inc's FY2025 earnings report, its debt-to-asset ratio was 19.15, with a year-on-year change of 125.20.
What is the Return on Equity (ROE) of ALX Oncology Holdings Inc?
According to ALX Oncology Holdings Inc's FY2025 earnings report, its Return on Equity (ROE) was -145.70, with a year-on-year change of -63.86.
What is the Return on Assets (ROA) of ALX Oncology Holdings Inc?
According to ALX Oncology Holdings Inc's FY2025 earnings report, its Return on Assets (ROA) was -98.34, with a year-on-year change of -42.33.
What is the operating profit of ALX Oncology Holdings Inc?
According to ALX Oncology Holdings Inc's FY2025 earnings report, its operating profit was -100.85M, with a year-on-year change of 29.21.